Tested Applications
| Positive WB detected in | HEK-293 cells, HeLa cells, Jurkat cells, hTERT-RPE1 cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:4000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
13215-1-AP targets RFPL1/2/3 in WB, IHC, IF, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag4090 Product name: Recombinant human RFPL3 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-288 aa of BC031689 Sequence: MAALFQEASSCPVCSDYLEKPMSLECGCTVCLKCINSLQKEPHGEDLLCCCCSMVSQRNKIRPNRQLERLVSHIKELEPKMKKILQMNPRMRKFQVDMTLDADTANNFLLISDDLRSVRSGLITQNRQDLAERFDVSVCILGSPRFTCGRHYWEVDVGTSTEWDLGVCRESVHCKGKIQLTTELGFWTVSLRDGSRLSASTVPLTFLLVDRKLQRVGIFLDMGMQNVSFFDAESGSHVYTFRSVSAEEPLRPFLAPSIPPNGDQGVLSICPLMNSGTTDAPVRPGEAK Predict reactive species |
| Full Name | ret finger protein-like 3 |
| Calculated Molecular Weight | 317 aa, 35 kDa |
| Observed Molecular Weight | 35-37 kDa |
| GenBank Accession Number | BC031689 |
| Gene Symbol | RFPL3 |
| Gene ID (NCBI) | 10738 |
| RRID | AB_2877925 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | O75679 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
RFPL1, RFPL2, and RFPL3 are highly homologous, primate-specific paralogous genes clustered on human chromosome 22q12.2-q13.3, with 95-96% cDNA identity. RFPL1/2/3 are expressed during human neurogenesis, suggesting roles in primate neocortical expansion. RFPL1 reduces cell number and controls cell-cycle progression by promoting cyclin B1/Cdc2 degradation. RFPL2 function remains poorly understood.
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for RFPL1/2/3 antibody 13215-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The RFPL1/2/3 Polyclonal antibody (Cat# 13215-1-AP) has 2 total citations. These appear in Oncology Reports (2018) and Discover Oncology (2025). Both studies focus on non-small cell lung cancer, with research fields centered on oncology and cancer signaling. The 2018 paper examined EGF upregulation of RFPL3 and hTERT via the MEK pathway, while the 2025 study explored targeted therapies against RFPL3 in lung cancer with lymph node metastasis. Applications cited include Western blot, immunofluorescence, and immunohistochemistry.
| Species | Application | Title |
|---|---|---|
Oncol Rep EGF upregulates RFPL3 and hTERT via the MEK signaling pathway in non‑small cell lung cancer cells. | ||
Discov Oncol Exploring targeted therapies against RFPL3 for non-small cell lung cancer with lymph node metastasis.
|



